Written from the studies on PubMed, searched on 11 Nov 2026. Every number below comes from a study listed under Sources.
What people read
Posts online say that Stem cell treatment helps with Amyloidosis.
What has been studied
- 12In people2 randomised trials
- 0In animals
- 0Only in the lab
What the studies found
Stem cell treatment has been tested in randomised trials in people with Amyloidosis.
We found 162 published papers on Stem cell treatment and Amyloidosis. They were published between 1999 and 2026.
12 of them are studies in people (2 randomised trials), 42 are reviews, 0 are studies in animals and 0 are studies only in the lab.
The most important ones are listed under Sources.
What this means for you: A study in people is not proof that it helps you. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial.2019 · Haematologica · Randomised trial
- High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial.2004 · Bone Marrow Transplant · Randomised trial
- Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study.2021 · Blood Cancer J · Study in people
- Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis.2019 · Am J Hematol · Study in people
- Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis.2019 · Biol Blood Marrow Transplant · Study in people
- Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis.2017 · Amyloid · Study in people
- Impact of Autologous Stem Cell Transplantation on the Incidence and Outcome of Oligoclonal Bands in Patients with Light-Chain Amyloidosis.2017 · Biol Blood Marrow Transplant · Study in people
- High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.2015 · Bone Marrow Transplant · Study in people
- Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology.2015 · Haematologica · Study in people
- Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.2014 · Bone Marrow Transplant · Study in people
- Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone.2008 · Br J Haematol · Study in people
- Immunoglobulin Light Chain Amyloidosis: 2026 Update on Diagnosis, Prognosis, and Treatment.2026 · Am J Hematol · Review
- Autologous stem cell transplantation in AL amyloidosis: Muddy waters.2024 · Blood Rev · Review
- Role of Autologous Stem Cell Transplantation in Systemic Light Chain Amyloidosis.2024 · Clin Lymphoma Myeloma Leuk · Review
- AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management.2023 · Ann Acad Med Singap · Review
- Autologous Stem Cell Transplant in Hodgkin's and Non-Hodgkin's Lymphoma, Multiple Myeloma, and AL Amyloidosis.2023 · Cells · Review
- Recent guidelines for high-dose chemotherapy and autologous stem cell transplant for systemic AL amyloidosis: a practitioner's perspective.2022 · Expert Rev Hematol · Review
- The early dFLC level after autologous stem cell transplantation can predict the long-term prognosis of in patients with light chain amyloidosis.2026 · Ann Hematol · Other paper
- Sequential Autologous Stem Cell Transplantation and Ciltacabtagene Autoleucel for Concurrent Multiple Myeloma and Presumptive Immunoglobulin Heavy- and Light-Chain Amyloidosis in a Patient With Systemic Lupus Erythematosus.2026 · Cureus · Other paper
- Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020.2026 · Bone Marrow Transplant · Other paper
- Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis.2026 · Am J Hematol · Other paper